Yoga as a non-pharmacological intervention for MPNs
Symptom burden in patients with myeloproliferative neoplasms (MPNs), in the form of fatigue, night sweats and weight loss, can remain severe even with the newest treatments. In this video, recorded at... Author: VJHemOnc Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts

Current treatment landscape in classical MPNs
The treatment landscape for myeloproliferative neoplasms (MPNs) is constantly evolving, as Ruben Mesa, MD, of UT Health San Antonio Cancer Center, San Antonio, TX, explains in this video, recorded at ... Author: VJHemOnc Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts

MPN therapies: the current landscape
Treatment of myeloproliferative neoplasms (MPNs) is expanding to include several exciting new therapies. We spoke to Claire Harrison, MD, FRCP, FRCPath, from Guy's and St Thomas' Hospital, London, UK ... Author: VJHemOnc Added: 07/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 23, 2018 Category: Cancer & Oncology Source Type: podcasts

Promising clinical trials for myeloproliferative neoplasms
An exciting array of data for myeloproliferative neoplasms (MPNs) was presented at the 2018 British Society for Hematology (BSH) Annual Scientific Meeting, held in Liverpool, UK. Speaking from the mee... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

The TAMARIN study: tamoxifen for MPNs
An upcoming study is investigating a new therapeutic strategy for the treatment of myeloproliferative neoplasms (MPNs). In this interview, Claire Harrison, MD, FRCP, FRCPath, from Guys and St Thomas... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Individualizing patient care in CML and MPNs
This is an exciting time for chronic myeloid leukemia (CML) and myeloproliferative neoplasms (MPNs), with new treatments on the horizon. Here, Claire Harrison, MD, FRCP, FRCPath, from Guy's and St Tho... Author: VJHemOnc Added: 05/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 4, 2018 Category: Cancer & Oncology Source Type: podcasts

Ruxolitinib plus decitabine in post-MPN AML
The outcomes of patients with post-myeloproliferative neoplasm acute myeloid leukemia (post-MPN AML) are poor, with no standard therapy. In this interview, Farhad Ravandi, MD, from the University of T... Author: VJHemOnc Added: 02/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 9, 2018 Category: Cancer & Oncology Source Type: podcasts

MPN (Myeloproliferative Neoplasm) & CHIP New phenomenon in aging individuals with mutations associated with MM
Angela Fleischman MD PhD UC Irvine discusses MPN (Myeloproliferative Neoplasm) & CHIP New phenomenon in aging individuals with mutations associated with MM at MOASCs Spotlight On Hematology in Huntin... Author: moasc Added: 02/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Updates in Myeloproliferative Neoplasm
Angela Fleischman, MD, from UC Irvine joins us at MOASCs Spotlight On Hematology in Huntington Beach to discusses the updates in myeloproliferative neoplasm, abstracts from ASH 2017 and papers that a... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 2, 2018 Category: Cancer & Oncology Source Type: podcasts

MPNs update from ASH 2017
In this exciting interview, Claire Harrison, MD, DM, FRCP, FRCPath, of Guy's and St Thomas' NHS Foundation Trust, London, UK, discusses the data on myeloproliferative neoplasms (MPNs) from the America... Author: VJHemOnc Added: 12/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Looking forward: MPN treatment
Myeloproliferative neoplasms (MPNs) are complex diseases, with current therapies primarily designed to prevent complications and reduce symptoms. In this insightful interview, Ruben Mesa, MD, from UT... Author: VJHemOnc Added: 12/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Potential of next-generation sequencing in the NHS for patients with MPNs
Myeloproliferative Neoplasms (MPNs) carry a risk of complications, such as thrombosis; the degree of risk is influenced in part by genetic factors. In this interview, recorded at the Myeloproliferativ... Author: VJHemOnc Added: 12/05/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 5, 2017 Category: Cancer & Oncology Source Type: podcasts

How Can I Educate My Primary Care Provider About Myeloproliferative Neoplasms?
In this Ask the Expert segment, Dr. Abdulraheem Yacoub responds to a question from a community member asking for advice on educating their primary care physician about their MPN.<br /><br />Get email alerts |... Author: patientpower Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 30, 2017 Category: Cancer & Oncology Source Type: podcasts

Is the order of mutations leading to cancer important?
Cancers, such as myeloproliferative neoplasms (MPNs), evolve from repeated mutations; it is unlikely that one mutation alone causes cancer. In this interview, Tony Green, MD, PhD, of the University of... Author: VJHemOnc Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts

The future of predicting outcomes for patients with MPNs: a patient knowledge bank
The discovery of various molecular risk factors for myeloproliferative neoplasms (MPNs) has revolutionized the way in which doctors diagnose these diseases, and the way that they determine the prognos... Author: VJHemOnc Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts